Answers are grounded in this paper and cite their sources.
Resistance of Candida albicans to triazoles is uncommon with short term treatment but has been increasingly reported in immunocompromised patients, including those with HIV infection who are receiving long term systemic or maintenance therapy. Vaginal triazole resistant C albicans isolates are extremely rare in non-immunocompromised HIV seronegative women.1 To our knowledge, only a single case has been reported to date.2 As over the counter oral triazole antifungals are now widely available there is potential for drug resistance to increase. We report another case of vulvovaginitis due to triazole resistant C albicans in an otherwise …
No takes yet. Share an insight, caveat, or question.
Lucy Dorrell (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: